Commodore Capital »

Perceptive Cap Solutions Cor Cl A shares owned by Commodore Capital

Quarter-by-quarter ownership of Perceptive Cap Solutions Cor Cl A (PCSC) shares owned by Commodore Capital from 13F filings

Historical chart of Commodore Capital investment in Perceptive Cap Solutions Cor Cl A

Tip: Access up to 7 years of quarterly data

All positions including Perceptive Cap Solutions Cor Cl A held by Commodore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perceptive Cap Solutions Cor Cl A by Commodore Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.5M 750k 10.01
2024-06-30 $7.5M 750k 10.06

More positions owned by Commodore Capital

Merus N V (MRUS)
Vera Therapeutics Cl A (VERA)
Xenon Pharmaceuticals (XENE)
Vaxcyte (PCVX)
Enliven Therapeutics (ELVN)
Nuvalent Inc-a (NUVL)
Cogent Biosciences (COGT)
Alkermes SHS (ALKS)
Soleno Therapeutics (SLNO)
Spyre Therapeutics Com New (SYRE)
Miragen Therapeutics (VRDN)
Celldex Therapeutics Com New (CLDX)
Mind Medicine Mindmed Com New (MNMD)
Perspective Therapeutics Com New (CATX)
Nurix Therapeutics (NRIX)

View all positions for Commodore Capital

Top funds holding Perceptive Cap Solutions Cor Cl A

Commodore Capital
VR Adviser
RA Capital Management
683 Capital Management
Shaolin Capital Management
OZ Management
Affinity Asset Advisors
Kepos Capital
Point72 Asset Management
Schonfeld Strategic Advisors
Stempoint Capital
Highbridge Capital Management
Two Sigma Investments
Tenor Capital Management
Cowen And Company

View all funds holding Perceptive Cap Solutions Cor Cl A